TESAI CARE S.L.

This company and project was born in the d·HEALTH Barcelona 2020 program (Biocat), a program that applies Stanford's Biodesign methodology to identify unmet clinical needs and design innovative solutions.

Disclaimer. heecap is not an approved product neither in the United States nor in Canada nor in Europe nor in any other region. All products and therapies are still in development and any statement arises from rationales or pre-clinical investigations which have yet to be completed.